NPs Basic Information

Name
Lycorine
Molecular Formula C16H17NO4
IUPAC Name*
(1S,17S,18S,19S)-5,7-dioxa-12-azapentacyclo[10.6.1.02,10.04,8.015,19]nonadeca-2,4(8),9,15-tetraene-17,18-diol
SMILES
C1CN2CC3=CC4=C(C=C3[C@H]5[C@H]2C1=C[C@@H]([C@H]5O)O)OCO4
InChI
InChI=1S/C16H17NO4/c18-11-3-8-1-2-17-6-9-4-12-13(21-7-20-12)5-10(9)14(15(8)17)16(11)19/h3-5,11,14-16,18-19H,1-2,6-7H2/t11-,14-,15+,16+/m0/s1
InChIKey
XGVJWXAYKUHDOO-DANNLKNASA-N
Synonyms
lycorine; 476-28-8; Amarylline; Galanthidine; Narcissine; Licorine; (-)-Lycorine; NSC401360; NSC683873; CHEBI:6601; CHEMBL400092; I9Q105R5BU; GNF-PF-4974; Lycoran-1-alpha,2-beta-diol, 3,3-alpha-didehydro-; NSC-401360; NSC-683873; 9,10-(methylenedioxy)-3,12-didehydrogalanthan-1alpha,2beta-diol; NSC 401360; Galanthan-1,2-diol, 3,12-didehydro-9,10-(methylenebis(oxy))-, (1-alpha,2-beta)-; (1S,2S,3a1S,12bS)-2,3a1,4,5,7,12b-hexahydro-1H-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol; (1S,2S,12bS,12cS)-2,4,5,7,12b,12c-hexahydro-1H-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol; EINECS 207-503-6; UNII-I9Q105R5BU; 3,3a-Didehydrolycoran-1alpha,2beta-diol; Likorin; (1S,2S,12BS,12CS)-2,4,5,7,12B,12C-HEXAHYDRO-1H-(1,3)DIOXOLO(4,5-J)PYRROLO(3,2,1-DE)PHENANTHRIDINE-1,2-DIOL; 3,2.beta.-diol; Lycoran-1.alpha.,2.beta.-diol, 3,3a-didehydro-; LYCORINE [MI]; Lycoran-1alpha,2beta-diol, 3,3a-didehydro-; BSPBio_001302; KBioGR_000022; KBioSS_000022; SCHEMBL626071; BCBcMAP01_000100; KBio2_000022; KBio2_002590; KBio2_005158; KBio3_000043; KBio3_000044; DTXSID60197208; Bio2_000022; Bio2_000502; HMS1361B04; HMS1791B04; HMS1989B04; HMS3402B04; HMS3885I12; HY-N0288; ZINC3881372; BDBM50221066; MFCD00221746; NSC781764; s3903; Lycoran-1.alpha., 3,3a-didehydro-; AKOS000278045; CCG-208232; NSC-781764; IDI1_033772; QTL1_000052; SMP1_000184; NCGC00163413-01; NCGC00163413-02; NCGC00163413-03; NCGC00163413-07; NCI60_003767; CS-0008781; C08532; Q420314; BRD-K64909280-001-02-7; 3,12-[methylenebis(oxy)]-galanthan-1.alpha.,2.beta.-diol; Galanthan-1, 3,12-didehydro-9,10-[methylenebis(oxy)]-, (1.alpha.,2.beta.)-; Galanthan-1, 3,4-didehydro-11,12-[methylenebis(oxy)]-, (1.alpha.,2.beta.)-; (1S,17S,18S,19S)-5,7-dioxa-12-azapentacyclo[10.6.1.0?,??.0?,?.0??,??]nonadeca-2,4(8),9,15-tetraene-17,18-diol; (1S,17S,18S,19S)-5,7-dioxa-12-azapentacyclo[10.6.1.02,10.04,8.015,19]nonadeca-2,4(8),9,15-tetraene-17,18-diol; 1H-[1,3]Dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol, 2,4,5,7,12b,12c-hexahydro-, (1S,2S,12bS,12cS)-; 2,4,5,7,12b,12c-Hexahydro-1H-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol, (1S,2S,12bS, 12cS)-; 2,5,7,12b,12c-Hexahydro-1H-[1,3]-dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol; 3KD
CAS 476-28-8
PubChem CID 72378
ChEMBL ID CHEMBL400092
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Alkaloids and derivatives
      • Class: Amaryllidaceae alkaloids
        • Subclass: Lycorine-type amaryllidac
          • Direct Parent: Lycorine-type amaryllidac

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 287.31 ALogp: 0.0
HBD: 2 HBA: 5
Rotatable Bonds: 0 Lipinski's rule of five: Accepted
Polar Surface Area: 62.2 Aromatic Rings: 5
Heavy Atoms: 21 QED Weighted: 0.701

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.654 MDCK Permeability: 0.00003040
Pgp-inhibitor: 0.004 Pgp-substrate: 0.499
Human Intestinal Absorption (HIA): 0.005 20% Bioavailability (F20%): 0.129
30% Bioavailability (F30%): 0.19

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.983 Plasma Protein Binding (PPB): 71.25%
Volume Distribution (VD): 2.527 Fu: 25.39%

ADMET: Metabolism

CYP1A2-inhibitor: 0.712 CYP1A2-substrate: 0.659
CYP2C19-inhibitor: 0.095 CYP2C19-substrate: 0.81
CYP2C9-inhibitor: 0.019 CYP2C9-substrate: 0.342
CYP2D6-inhibitor: 0.938 CYP2D6-substrate: 0.733
CYP3A4-inhibitor: 0.152 CYP3A4-substrate: 0.32

ADMET: Excretion

Clearance (CL): 16.253 Half-life (T1/2): 0.479

ADMET: Toxicity

hERG Blockers: 0.023 Human Hepatotoxicity (H-HT): 0.057
Drug-inuced Liver Injury (DILI): 0.106 AMES Toxicity: 0.124
Rat Oral Acute Toxicity: 0.859 Maximum Recommended Daily Dose: 0.929
Skin Sensitization: 0.05 Carcinogencity: 0.945
Eye Corrosion: 0.003 Eye Irritation: 0.013
Respiratory Toxicity: 0.965
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC001089 0.302 D0L1JW 0.330
ENC001059 0.293 D0D4HN 0.292
ENC000361 0.292 D0M4XY 0.278
ENC001035 0.278 D07UXP 0.267
ENC005030 0.274 D0W8WB 0.264
ENC001881 0.266 D09NIB 0.259
ENC000812 0.263 D04TDQ 0.248
ENC003417 0.243 D06GDY 0.245
ENC001426 0.242 D01DBQ 0.237
ENC001086 0.224 D05MQK 0.229
*Note: the compound similarity was calculated by RDKIT.